Recall alert: G-Supress DX Pediatric Drops recalled

The Food and Drug Administration has announced the recall of a specific lot of over-the-counter G-Supress DX Pediatric Drops. It was only sent to Puerto Rico, officials said.

>> Read more trending news

The medication, which the FDA identified as the cherry flavor of “G-Supress DX Pediatric Drops Cough Suppressant Expectorant Nasal Decongestant,” was made by Novis PR LLC.

The lot contains the wrong product and could harm a patient, the FDA said.

Pharmacies contacted Novis alerting the company that the cartons of G-Supress actually contained Finafta Anesthetic/Analgesic Liquid, a medication that temporarily relieves mouth irritations and inflammation.

The anesthetic/analgesic contains 60% ethyl alcohol and 5% benzocaine.

The FDA warns against young children ingesting either ingredient.

“Infants and young children are at higher risk of developing alcohol toxicity, profound hypoglycemia (low blood sugar), coma, hypothermia (low body temperature), or death from ingesting even relatively small amounts of ethanol. Benzocaine can cause methemoglobinemia, a potentially life-threatening condition where too little oxygen is delivered to your cells,” the FDA said.

The only G-Supress DX Pediatric Drops affected is Lot D20911 with an expiration date of 10/25.

So far there have not been any reports of injuries related to the product, the FDA reported.

If you have any questions, you can contact Novis at 787-767-2072 Monday through Friday from 8 a.m. to 4 p.m. EDT.

Comments on this article